(RHM) Rheinmetall - Overview
Stock: Combat Vehicles, Ammunition, Sensors, Actuators, Bearings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.51% |
| Yield on Cost 5y | 10.00% |
| Yield CAGR 5y | 41.86% |
| Payout Consistency | 90.5% |
| Payout Ratio | 88.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.4% |
| Relative Tail Risk | -5.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.73 |
| Alpha | 120.55 |
| Character TTM | |
|---|---|
| Beta | -0.150 |
| Beta Downside | -0.303 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.43% |
| CAGR/Max DD | 3.29 |
Description: RHM Rheinmetall January 28, 2026
Rheinmetall AG (XETRA:RHM) is a German-based defense and mobility technology group operating worldwide across five segments: Vehicle Systems (armored and logistics vehicles, CBRN protection, artillery), Weapon & Ammunition (fire-power, protection systems, propellants), Electronic Solutions (sensors, networking, cyber-protection, training simulators), Power Systems (e-mobility, thermal management, hydrogen technology, bearings, pumps) and various aftermarket services. The firm traces its roots to 1889 and has been listed as Rheinmetall AG since 1996.
In FY 2025 the company reported €7.3 billion of revenue, a 4.2 % YoY increase, driven primarily by a 9 % rise in defense-related orders and a 6 % expansion in its Power Systems e-mobility portfolio. The order backlog stood at roughly €9 billion, with defense contracts representing about 68 % of the total, reflecting the broader European defence-spending surge of ~3 % YoY amid heightened NATO commitments. On the profitability side, EBIT margin improved to 8.3 % (up from 7.5 % in FY 2024) as the company leveraged higher unit pricing on armored platforms and cost-saving initiatives in its electronic-solutions division.
For a deeper quantitative view, you might explore the detailed valuation metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 840.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -6.43 > 1.0 |
| NWC/Revenue: 10.04% < 20% (prev 17.19%; Δ -7.15% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.01b > Net Income 840.0m |
| Net Debt (1.87b) to EBITDA (1.96b): 0.96 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.9m) vs 12m ago 3.75% < -2% |
| Gross Margin: 44.76% > 18% (prev 0.30%; Δ 4446 % > 0.5%) |
| Asset Turnover: 78.16% > 50% (prev 70.70%; Δ 7.46% > 0%) |
| Interest Coverage Ratio: 11.47 > 6 (EBITDA TTM 1.96b / Interest Expense TTM 129.0m) |
Altman Z'' 2.16
| A: 0.07 (Total Current Assets 9.28b - Total Current Liabilities 8.17b) / Total Assets 15.66b |
| B: 0.20 (Retained Earnings 3.19b / Total Assets 15.66b) |
| C: 0.11 (EBIT TTM 1.48b / Avg Total Assets 14.07b) |
| D: 0.31 (Book Value of Equity 3.28b / Total Liabilities 10.51b) |
| Altman-Z'' Score: 2.16 = BBB |
Beneish M -3.20
| DSRI: 0.94 (Receivables 2.96b/2.52b, Revenue 11.00b/8.83b) |
| GMI: 0.67 (GM 44.76% / 29.98%) |
| AQI: 1.01 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 1.25 (Revenue 11.00b / 8.83b) |
| TATA: -0.01 (NI 840.0m - CFO 1.01b) / TA 15.66b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of RHM shares?
Over the past week, the price has changed by -7.20%, over one month by -13.32%, over three months by -10.21% and over the past year by +120.60%.
Is RHM a buy, sell or hold?
What are the forecasts/targets for the RHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2196.7 | 36.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2838.8 | 76.9% |
RHM Fundamental Data Overview February 03, 2026
P/E Trailing = 94.5093
P/E Forward = 46.2963
P/S = 7.4123
P/B = 17.5859
P/EG = 1.0704
Revenue TTM = 11.00b EUR
EBIT TTM = 1.48b EUR
EBITDA TTM = 1.96b EUR
Long Term Debt = 1.20b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.23b EUR (from shortTermDebt, last quarter)
Debt = 2.43b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.87b EUR (from netDebt column, last quarter)
Enterprise Value = 83.39b EUR (81.52b + Debt 2.43b - CCE 557.0m)
Interest Coverage Ratio = 11.47 (Ebit TTM 1.48b / Interest Expense TTM 129.0m)
EV/FCF = 851.0x (Enterprise Value 83.39b / FCF TTM 98.0m)
FCF Yield = 0.12% (FCF TTM 98.0m / Enterprise Value 83.39b)
FCF Margin = 0.89% (FCF TTM 98.0m / Revenue TTM 11.00b)
Net Margin = 7.64% (Net Income TTM 840.0m / Revenue TTM 11.00b)
Gross Margin = 44.76% ((Revenue TTM 11.00b - Cost of Revenue TTM 6.08b) / Revenue TTM)
Gross Margin QoQ = 21.65% (prev 53.42%)
Tobins Q-Ratio = 5.33 (Enterprise Value 83.39b / Total Assets 15.66b)
Interest Expense / Debt = 1.11% (Interest Expense 27.0m / Debt 2.43b)
Taxrate = 30.0% (87.0m / 290.0m)
NOPAT = 1.04b (EBIT 1.48b * (1 - 30.00%))
Current Ratio = 1.14 (Total Current Assets 9.28b / Total Current Liabilities 8.17b)
Debt / Equity = 0.52 (Debt 2.43b / totalStockholderEquity, last quarter 4.67b)
Debt / EBITDA = 0.96 (Net Debt 1.87b / EBITDA 1.96b)
Debt / FCF = 19.11 (Net Debt 1.87b / FCF TTM 98.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.97% (Net Income 840.0m / Total Assets 15.66b)
RoE = 19.04% (Net Income TTM 840.0m / Total Stockholder Equity 4.41b)
RoCE = 26.36% (EBIT 1.48b / Capital Employed (Equity 4.41b + L.T.Debt 1.20b))
RoIC = 20.98% (NOPAT 1.04b / Invested Capital 4.94b)
WACC = 5.23% (E(81.52b)/V(83.95b) * Re(5.36%) + D(2.43b)/V(83.95b) * Rd(1.11%) * (1-Tc(0.30)))
Discount Rate = 5.36% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF Debug] Terminal Value 86.82% ; FCFF base≈411.2m ; Y1≈432.3m ; Y5≈506.0m
Fair Price DCF = 287.1 (EV 15.01b - Net Debt 1.87b = Equity 13.14b / Shares 45.8m; r=5.90% [WACC]; 5y FCF grow 5.59% → 2.90% )
EPS Correlation: 27.89 | EPS CAGR: -8.53% | SUE: -1.21 | # QB: 0
Revenue Correlation: 73.81 | Revenue CAGR: 12.01% | SUE: -0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.32 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=43.35 | Chg30d=-0.447 | Revisions Net=-1 | Growth EPS=+49.5% | Growth Revenue=+47.5%